Newsmax Inc.·4

May 21, 4:57 PM ET

Cox Christopher Nixon 4

4 · Newsmax Inc. · Filed May 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Newsmax (NMAX) Director Christopher Cox Receives Option Grant

What Happened

  • Director Christopher Cox received a grant of derivative securities (an option award) for 23,940 shares of Newsmax (NMAX) on 2026-05-20. The reported acquisition value is $0.00 (award/grant), i.e., no cash was paid by the insider for the grant. The option will become exercisable on the 12-month anniversary of the grant date, contingent on continued service.

Key Details

  • Transaction date: 2026-05-20 (reported on Form 4 filed 2026-05-21).
  • Transaction type/code: A (Award/Grant of derivative securities).
  • Shares/options: 23,940 (reported at $0.00 acquisition value).
  • Exercisability/vesting: Becomes exercisable on the 12-month anniversary of the grant date, subject to continued service (per filing footnote).
  • Shares owned after transaction: Not specified in the provided summary of the filing.
  • Timeliness: Filing appears timely (filed one day after the grant).
  • Footnote: Grant made under the Issuer’s 2025 Omnibus Equity Incentive Plan and governed by a Stock Option Grant Notice and Option Agreement.

Context

  • This is an equity incentive award (options), not a cash purchase or sale. It gives the holder the right to acquire shares in the future if and when the options vest and are exercised; it does not represent immediate proceeds or a current sale of stock.
  • Such grants are common as compensation for directors and do not by themselves indicate a buy/sell signal. The option’s exercise price and further terms are in the underlying option agreement and are not detailed in this summary.

Insider Transaction Report

Form 4
Period: 2026-05-20
Transactions
  • Award

    Option (Right to Buy)

    [F1]
    2026-05-20+23,94023,940 total
    Exercise: $7.31From: 2027-05-20Exp: 0036-05-20Class B Common Stock (23,940 underlying)
Footnotes (1)
  • [F1]The option was granted pursuant to the Issuer's 2025 Omnibus Equity Incentive Plan and a Stock Option Grant Notice and Option Agreement. The option shall become exercisable on the 12-month anniversary of the grant date, provided that the Reporting Person continues to provide services to the Issuer through such date.
Signature
/s/ Darryle Burnham as Attorney-In-Fact for Christopher Nixon Cox|2026-05-21

Documents

1 file
  • 4
    wk-form4_1779397037.xmlPrimary

    FORM 4